Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2016 | 06-2015 | 06-2014 | 06-2013 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 117,200 | 80,200 | 176,200 | 147,200 | 112,151 |
| Depreciation Amortization | 26,800 | 25,000 | 13,800 | 8,900 | 9,069 |
| Income taxes - deferred | 13,200 | -400 | 8,100 | 7,400 | 33,625 |
| Accounts receivable | -25,900 | -34,400 | -24,400 | -67,200 | -34,986 |
| Accounts payable and accrued liabilities | 0 | -3,100 | -1,500 | 8,000 | -1,249 |
| Other Working Capital | -52,500 | -40,700 | -60,000 | -40,900 | -28,803 |
| Other Operating Activity | 87,500 | 113,900 | 78,000 | 110,500 | 51,997 |
| Operating Cash Flow | $166,300 | $140,500 | $190,200 | $173,900 | $141,804 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -5,000 | N/A |
| PPE Investments | -5,000 | -23,900 | -14,300 | -11,400 | -9,408 |
| Net Acquisitions | -37,000 | -20,100 | -223,500 | N/A | -8,799 |
| Purchase Of Investment | -164,500 | -80,700 | -161,800 | -443,800 | -388,067 |
| Sale Of Investment | 115,100 | 165,600 | 382,500 | 385,300 | 385,236 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -750 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -17,850 |
| Investing Cash Flow | $-91,400 | $40,900 | $-17,100 | $-74,900 | $-38,888 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 94,300 | 30,000 | 64,800 | 57,800 | 25,029 |
| Common Stock Repurchased | -162,600 | -210,700 | -287,700 | -146,300 | -128,467 |
| Other Financing Activity | 0 | 3,400 | 11,100 | 7,900 | 34,193 |
| Financing Cash Flow | $-68,300 | $-177,300 | $-211,800 | $-80,600 | $-69,245 |
| Exchange Rate Effect | -2,200 | -4,800 | -600 | -700 | N/A |
| Beginning Cash Position | 64,100 | 64,800 | 104,100 | 86,400 | 52,681 |
| End Cash Position | 68,500 | 64,100 | 64,800 | 104,100 | 86,352 |
| Net Cash Flow | $4,400 | $-700 | $-39,300 | $17,700 | $33,671 |
| Free Cash Flow | |||||
| Operating Cash Flow | 166,300 | 140,500 | 190,200 | 173,900 | 141,804 |
| Capital Expenditure | -5,000 | -23,900 | -14,300 | -11,400 | -9,408 |
| Free Cash Flow | 161,300 | 116,600 | 175,900 | 162,500 | 132,396 |